Cannabis, pain and autoimmunity

Abstract

The constant search to improve the quality of life of the population leads us to obtain medicines to prevent and better treat diseases. In this search, substances already known for other properties, acquire relevance when their effectiveness can be demonstrated to improve the evolution of some pathologies. On the occasion of the enactment of the Law of Medicinal Use of the Cannabis Plant and its current regulations, the problem in the use of its derivatives in the treatment of painful medical conditions and autoimmune diseases acquires particular importance. In this sense, it is appropriate that medical societies in general and in this case, the Argentine Society of Rheumatology in particular, give rise to a space for publication and discussion of this topic.